Literature DB >> 17136124

IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan.

M A Salih1, M E Ibrahim, J M Blackwell, E N Miller, E A G Khalil, A M ElHassan, A M Musa, H S Mohamed.   

Abstract

Post-kala-azar dermal leishmanaisis (PKDL) in Sudan is associated with elevated interferon-gamma (IFN-gamma). To study interferon-gamma pathways in PKDL, we genotyped 80 trios from the Masalit ethnic group for polymorphisms at -470 ins/delTT, -270T/C, -56T/C and +95T/C in IFNGR1 and at -179G/A and +874T/A in IFNG. No associations occurred at IFNG. Global association with haplotypes comprising all four markers at IFNGR1 (chi(2)(10df)=21.97, P=0.015) was observed, associated with a significant (chi(2)(1df)=4.54, P=0.033) bias in transmission of the haplotype insTT T T T and less (chi(2)(1df)=5.59, P=0.018) than expected transmission of insTT C C C. When compared with data on malaria associations from Gambia, the results suggest a complex pattern of haplotypic variation at the IFNGR1 promoter locus associated with different infectious disease in African populations that reflect the complex roles of IFN-gamma in parasite killing versus inflammation and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17136124      PMCID: PMC2330095          DOI: 10.1038/sj.gene.6364353

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  15 in total

1.  Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile.

Authors:  A Ismail; A M El Hassan; K Kemp; S Gasim; A E Kadaru; T Moller; A Kharazmi; T G Theander
Journal:  J Pathol       Date:  1999-12       Impact factor: 7.996

2.  A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production.

Authors:  V Pravica; C Perrey; A Stevens; J H Lee; I V Hutchinson
Journal:  Hum Immunol       Date:  2000-09       Impact factor: 2.850

3.  Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis.

Authors:  E E Zijlstra; A M el-Hassan
Journal:  Trans R Soc Trop Med Hyg       Date:  2001-04       Impact factor: 2.184

4.  IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria.

Authors:  Oliver Koch; Agnes Awomoyi; Stanley Usen; Muminatou Jallow; Anna Richardson; Jeremy Hull; Margaret Pinder; Melanie Newport; Dominic Kwiatkowski
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

5.  Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.

Authors:  H S Mohamed; M E Ibrahim; E N Miller; C S Peacock; E A G Khalil; H J Cordell; J M M Howson; A M El Hassan; R E H Bereir; J M Blackwell
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

6.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription.

Authors:  J H Bream; A Ping; X Zhang; C Winkler; H A Young
Journal:  Genes Immun       Date:  2002-05       Impact factor: 2.676

8.  Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I.

Authors:  Simone Jüliger; Martina Bongartz; Adrian J F Luty; Peter G Kremsner; Jürgen F J Kun
Journal:  Immunogenetics       Date:  2002-12-14       Impact factor: 2.846

9.  Interferon-gamma receptor-1 gene promoter polymorphisms (G-611A; T-56C) and susceptibility to tuberculosis.

Authors:  L Bulat-Kardum; G E Etokebe; J Knezevic; S Balen; N Matakovic-Mileusnic; L Zaputovic; J Pavelic; Z Beg-Zec; Z Dembic
Journal:  Scand J Immunol       Date:  2006-02       Impact factor: 3.487

10.  No association between interferon-gamma receptor-1 gene polymorphism and pulmonary tuberculosis in a Gambian population sample.

Authors:  A A Awomoyi; S Nejentsev; A Richardson; J Hull; O Koch; M Podinovskaia; J A Todd; K P W J McAdam; J M Blackwell; D Kwiatkowski; M J Newport
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

View more
  14 in total

Review 1.  Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.

Authors:  Hui-Qi Qu; Susan P Fisher-Hoch; Joseph B McCormick
Journal:  Int J Infect Dis       Date:  2011-02-16       Impact factor: 3.623

2.  IFNG +874 T>A single nucleotide polymorphism is associated with leprosy among Brazilians.

Authors:  C C Cardoso; A C Pereira; V N Brito-de-Souza; I M Dias-Baptista; V C Maniero; J Venturini; F R Vilani-Moreno; F C de Souza; M Ribeiro-Alves; E N Sarno; A G Pacheco; M O Moraes
Journal:  Hum Genet       Date:  2010-08-17       Impact factor: 4.132

Review 3.  Genetics and visceral leishmaniasis: of mice and man.

Authors:  J M Blackwell; M Fakiola; M E Ibrahim; S E Jamieson; S B Jeronimo; E N Miller; A Mishra; H S Mohamed; C S Peacock; M Raju; S Sundar; M E Wilson
Journal:  Parasite Immunol       Date:  2009-05       Impact factor: 2.280

4.  Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever.

Authors:  Giusi Irma Forte; Letizia Scola; Gabriella Misiano; Salvatore Milano; Pasquale Mansueto; Giustina Vitale; Fiamma Bellanca; Maria Sanacore; Loredana Vaccarino; Giovan Battista Rini; Calogero Caruso; Enrico Cillari; Domenico Lio; Serafino Mansueto
Journal:  Clin Vaccine Immunol       Date:  2009-04-22

Review 5.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

6.  Type I IFNs downregulate myeloid cell IFN-γ receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription.

Authors:  Staci J Kearney; Christine Delgado; Emily M Eshleman; Krista K Hill; Brian P O'Connor; Laurel L Lenz
Journal:  J Immunol       Date:  2013-08-09       Impact factor: 5.422

7.  Genetic control of canine leishmaniasis: genome-wide association study and genomic selection analysis.

Authors:  Javier Quilez; Verónica Martínez; John A Woolliams; Armand Sanchez; Ricardo Pong-Wong; Lorna J Kennedy; Rupert J Quinnell; William E R Ollier; Xavier Roura; Lluís Ferrer; Laura Altet; Olga Francino
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

Review 8.  Post kala-azar dermal leishmaniasis: an unresolved mystery.

Authors:  Debanjan Mukhopadhyay; Jane E Dalton; Paul M Kaye; Mitali Chatterjee
Journal:  Trends Parasitol       Date:  2014-01-02

9.  Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.

Authors:  Mohamed A M Salih; Michaela Fakiola; Mohamed H Abdelraheem; Brima M Younis; Ahmed M Musa; Ahmed M ElHassan; Jenefer M Blackwell; Muntaser E Ibrahim; Hiba S Mohamed
Journal:  BMC Infect Dis       Date:  2014-12-03       Impact factor: 3.090

10.  Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol.

Authors:  D Mondal; M G Hasnain; M S Hossain; D Ghosh; P Ghosh; H Hossain; J Baker; R Nath; R Haque; G Matlashewski; S Hamano
Journal:  BMJ Open       Date:  2016-05-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.